MOZARNIS Trademark

Trademark Overview

On Friday, September 27, 2013, a trademark application was filed for MOZARNIS with the United States Patent and Trademark Office. The USPTO has given the MOZARNIS trademark a serial number of 86076989. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 22, 2017. This trademark is owned by Glaxo Group Limited. The MOZARNIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
mozarnis

General Information

Serial Number86076989
Word MarkMOZARNIS
Filing DateFriday, September 27, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 22, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 18, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events

Event DateEvent Description
Monday, May 22, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 22, 2017ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 17, 2016EXTENSION 5 GRANTED
Monday, September 12, 2016EXTENSION 5 FILED
Monday, September 12, 2016TEAS EXTENSION RECEIVED
Friday, April 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 7, 2016EXTENSION 4 GRANTED
Thursday, March 3, 2016EXTENSION 4 FILED
Wednesday, April 6, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 3, 2016TEAS EXTENSION RECEIVED
Friday, September 18, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 17, 2015EXTENSION 3 GRANTED
Tuesday, September 8, 2015EXTENSION 3 FILED
Thursday, September 17, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 8, 2015TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 2, 2015EXTENSION 2 GRANTED
Thursday, March 26, 2015EXTENSION 2 FILED
Saturday, May 2, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 26, 2015TEAS EXTENSION RECEIVED
Thursday, October 2, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 30, 2014EXTENSION 1 GRANTED
Tuesday, September 30, 2014EXTENSION 1 FILED
Tuesday, September 30, 2014TEAS EXTENSION RECEIVED
Tuesday, April 15, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, January 11, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 10, 2014ASSIGNED TO EXAMINER
Friday, October 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 1, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

mozarnis pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological